Filing Flows › Bio-Techne (TECH) › Capital expenditures
Bio-Techne (TECH) capital expenditures by quarter
Bio-Techne's capital expenditures were $5.9M in Q1 FY27 (first quarter fiscal 2027), -30% from Q4 FY26. Over the last 7 quarters it ranged from $4.9M (Q4 FY25) to $10.1M (Q3 FY25).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $5.9M | -30% | +10% |
| Q4 FY26 | $8.5M | -7% | +73% |
| Q3 FY26 | $9.1M | +53% | -10% |
| Q2 FY26 | $5.9M | +10% | — |
| Q1 FY26 | $5.4M | +10% | — |
| Q4 FY25 | $4.9M | -52% | — |
| Q3 FY25 | $10.1M | — | — |
Q1 FY27 at a glance
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Techne's capital expenditures?
Bio-Techne's capital expenditures were $5.9M in Q1 FY27 (first quarter fiscal 2027), -30% from Q4 FY26.
How has Bio-Techne's capital expenditures changed?
Over the last 7 quarters it ranged from $4.9M (Q4 FY25) to $10.1M (Q3 FY25).